Vanguard lists zero holdings in iRhythm (NASDAQ: IRTC)
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 7 to a Schedule 13G/A reporting 0 shares of iRhythm Holdings Inc. common stock as of 03/13/2026. The filing explains an internal realignment on January 12, 2026 that caused certain Vanguard subsidiaries and business divisions to report beneficial ownership separately. The amendment is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard reports zero beneficial ownership after an internal reorganization.
The filing lists 0 shares beneficially owned and 0% of the class as of 03/13/2026. It attributes the change to an internal realignment on January 12, 2026 and states certain subsidiaries will report separately.
Cash‑flow treatment and trading intent are not described; subsequent filings may show new subsidiary-level positions. This amendment is administrative and does not, by itself, indicate a change in economic exposure reported at the subsidiary level.
FAQ
What does Vanguard report for iRhythm (IRTC) in Amendment No. 7?
Does the filing explain why ownership changed for IRTC?
Who signed the Schedule 13G/A amendment for IRTC?
Does the amendment show any Vanguard entities still hold IRTC shares?